Awarded
Measles, mumps and rubella (MMR) vaccine 2027-2028 (2029, 2030)
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Winners
- MSD Finland Oy
- Contract value
- €5,097,600
- Bids received
- 1
- Published
- 7 Sept 2026
- Awarded
- 26 Aug 2026
- Contract start
- 26 Aug 2026
- Contract end
- 12 Sept 2027estimated
- Region
- Helsinki-Uusimaa
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| Tuberculosis (BCG) vaccine 2027-2029 (2029-2030, 2030-2031) | Ministry of Social Affairs and Health | Aj Vaccines | €529,920 | 5 Oct 2026 |
| Diphtheria and Tetanus (dT) vaccine 2027-2029 (2029-2030, 2030-2031) | Ministry of Social Affairs and Health | Aj Vaccines | €6,535,680 | 2 Oct 2026 |
| Hepatitis B (HBV) vaccine for children and adults 2027-2029 (2029-2030,2030-2031) | Ministry of Social Affairs and Health | GlaxoSmithKline Oy | €2,556,000 | 25 Sept 2026 |
| Pentavalent (DTaP-IPV+Hib) vaccine 2027-2028 (2029, 2030, 2031) | Ministry of Social Affairs and Health | Sanofi Oy | €11,088,000 | 7 Sept 2026 |